LILRB2
Leukocyte immunoglobulin-like receptor subfamily B member 2
Also known as: CD85d, ILT4, LIR-2, LIR2, LIRB2_HUMAN, MIR-10, MIR10
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N423
- Gene
- LILRB2
- Ensembl
- ENSG00000131042
- Chromosome
- 19
- Canonical length
- 597 aa
- Protein class
- CD markers, Predicted membrane proteins
OverviewNCBI Gene
This gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family, which is found in a gene cluster at chromosomal region 19q13.4. The encoded protein belongs to the subfamily B class of LIR receptors which contain two or four extracellular immunoglobulin domains, a transmembrane domain, and two to four cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). The receptor is expressed on immune cells where it binds to MHC class I molecules on antigen-presenting cells and transduces a negative signal that inhibits stimulation of an immune response. It is thought to control inflammatory responses and cytotoxicity to help focus the immune response and limit autoreactivity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
597 residues, UniProt reviewed canonical sequence.
>Q8N423|LILRB2
1 MTPIVTVLIC LGLSLGPRTR VQTGTIPKPT LWAEPDSVIT QGSPVTLSCQ GSLEAQEYRL
61 YREKKSASWI TRIRPELVKN GQFHIPSITW EHTGRYGCQY YSRARWSELS DPLVLVMTGA
121 YPKPTLSAQP SPVVTSGGRV TLQCESQVAF GGFILCKEGE DEHPQCLNSQ PHARGSSRAI
181 FSVGPVSPNR RWSHRCYGYD LNSPYVWSSP SDLLELLVPG VSKKPSLSVQ PGPVMAPGES
241 LTLQCVSDVG YDRFVLYKEG ERDLRQLPGR QPQAGLSQAN FTLGPVSRSY GGQYRCYGAH
301 NLSSECSAPS DPLDILITGQ IRGTPFISVQ PGPTVASGEN VTLLCQSWRQ FHTFLLTKAG
361 AADAPLRLRS IHEYPKYQAE FPMSPVTSAH AGTYRCYGSL NSDPYLLSHP SEPLELVVSG
421 PSMGSSPPPT GPISTPGPED QPLTPTGSDP QSGLGRHLGV VIGILVAVVL LLLLLLLLFL
481 ILRHRRQGKH WTSTQRKADF QHPAGAVGPE PTDRGLQWRS SPAADAQEEN LYAAVKDTQP
541 EDGVEMDTRA AASEAPQDVT YAQLHSLTLR RKATEPPPSQ EREPPAEPSI YATLAIHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LILRB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 49 nTPM
Expression across tissuesHPA
Tissue
- spleen: 49 nTPM
- bone marrow: 33 nTPM
- lung: 14 nTPM
- appendix: 11 nTPM
- adipose tissue: 6.2 nTPM
- blood vessel: 4.7 nTPM
Single-cell type
- monocytes: 38 nCPM
- neutrophils: 17 nCPM
- microglia: 13 nCPM
- kupffer cells: 10 nCPM
- macrophages: 8.6 nCPM
- cdc: 8.5 nCPM
Immune cell
- non-classical monocyte: 152 nTPM
- intermediate monocyte: 131 nTPM
- neutrophil: 63 nTPM
- classical monocyte: 61 nTPM
- total PBMC: 30 nTPM
- myeloid DC: 19 nTPM
Brain region
- medulla oblongata: 1.7 nTPM
- thalamus: 1.7 nTPM
- choroid plexus: 1.2 nTPM
- cerebral cortex: 1.1 nTPM
- pons: 1.1 nTPM
- white matter: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- -2.3
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- cell surface receptor signaling pathway
- cell-cell signaling
- cellular defense response
- cellular response to lipopolysaccharide
- Fc receptor mediated inhibitory signaling pathway
- heterotypic cell-cell adhesion
- immune response
- immune response-inhibiting cell surface receptor signaling pathway
- immune response-regulating signaling pathway
- interleukin-10-mediated signaling pathway
- learning or memory
- negative regulation of calcium ion transport
- negative regulation of postsynaptic density organization
- negative regulation of protein metabolic process
- negative regulation of T cell costimulation
- negative regulation of T cell proliferation
- positive regulation of interleukin-6 production
- positive regulation of long-term synaptic depression
- positive regulation of regulatory T cell differentiation
- positive regulation of T cell proliferation
- positive regulation of T cell tolerance induction
- positive regulation of tolerance induction
- regulation of dendritic cell differentiation
- regulation of long-term synaptic potentiation
- signal transduction
- negative regulation of antigen processing and presentation
Molecular functions
- amyloid-beta binding
- cell adhesion molecule binding
- inhibitory MHC class I receptor activity
- MHC class I protein binding
- MHC class Ib protein binding
- MHC class Ib protein complex binding
- protein homodimerization activity
- protein phosphatase 1 binding
- protein-containing complex binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LILRB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LILRB2 as an antibody target. Whether an autoantibody or antibody against LILRB2 could matter depends on whether native LILRB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LILRB2 is annotated at the cell surface, where native LILRB2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LILRB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...